NCT05500508: An ongoing trial by Aminex Therapeutics, Inc.
This trial is ongoing. It must report results 1 week from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05500508 |
|---|---|
| Title | A Phase 1B/2A Study of the Safety, Tolerability and Initial Efficacy of Oral AMXT 1501 Dicaprate and Intravenous Difluoromethylornithine (DFMO) in Patients With Cancer |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Nov. 29, 2022 |
| Completion date | Dec. 12, 2024 |
| Required reporting date | Dec. 12, 2025, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 3, 2025 |
| Days late | None |